title: Biological and enzymatic activities of Micrurus sp. (Coral) snake venoms.
abstract: The venoms of Micrurus lemniscatus carvalhoi, Micrurus frontalis frontalis, Micrurus surinamensis surinamensis and Micrurus nigrocinctus nigrocinctus were assayed for biological activities. Although showing similar liposome disrupting and myotoxic activities, M. frontalis frontalis and M. nigrocinctus nigrocinctus displayed higher anticoagulant and phospholipase A2 (PLA2) activities. The latter induced a higher edema response within 30 min. Both venoms were the most toxic as well. In the isolated chick biventer cervicis preparation, M. lemniscatus carvalhoi venom blocked the indirectly elicited twitch-tension response (85+/-0.6% inhibition after a 15 min incubation at 5 microg of venom/mL) and the response to acetylcholine (ACh; 55 or 110 microM), without affecting the response to KCl (13.4 mM). In mouse phrenic nerve-diaphragm preparation, the venom (5 microg/mL) produced a complete inhibition of the indirectly elicited contractile response after 50 min incubation and did not affect the contractions elicited by direct stimulation. M. lemniscatus carvalhoi inhibited 3H-L-glutamate uptake in brain synaptosomes in a Ca2+-, but not time, dependent manner. The replacement of Ca2+ by Sr2+ and ethylene glycol-bis(beta-aminoethyl ether) (EGTA), or alkylation of the venom with p-bromophenacyl bromide (BPB), inhibited 3H-L-glutamate uptake. M. lemniscatus carvalhoi venom cross-reacted with postsynaptic alpha-neurotoxins short-chain (antineurotoxin-II) and long-chain (antibungarotoxin) antibodies. It also cross-reacted with antimyotoxic PLA2 antibodies from M. nigrocinctus nigrocinctus (antinigroxin). Our results point to the need of catalytic activity for these venoms to exert their neurotoxic activity efficiently and to their components as attractive tools for the study of molecular targets on cell membranes.
authors.affiliation: Departamento de Física e Química, FCFRP, USP, Ribeirão Preto-SP, Brazil.
authors.forename: Alessandra L
authors.initials: AL
authors.lastname: Cecchini
authors.forename: Silvana
authors.initials: S
authors.lastname: Marcussi
authors.forename: Lucas B
authors.initials: LB
authors.lastname: Silveira
authors.forename: Caroline R
authors.initials: CR
authors.lastname: Borja-Oliveira
authors.forename: Léa
authors.initials: L
authors.lastname: Rodrigues-Simioni
authors.forename: Susan
authors.initials: S
authors.lastname: Amara
authors.forename: Rodrigo G
authors.initials: RG
authors.lastname: Stábeli
authors.forename: José R
authors.initials: JR
authors.lastname: Giglio
authors.forename: Eliane C
authors.initials: EC
authors.lastname: Arantes
authors.forename: Andreimar M
authors.initials: AM
authors.lastname: Soares
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology; D001681:Biological Assay; D001692:Biological Transport / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D004546:Elapid Venoms / Q000201:enzymology* / Q000276:immunology / Q000494:pharmacology*; D017815:Elapidae / Q000502:physiology*; D018698:Glutamic Acid / Q000378:metabolism; D008081:Liposomes / Q000378:metabolism; D051379:Mice; D009132:Muscles / Q000187:drug effects; D009498:Neurotoxins / Q000276:immunology / Q000494:pharmacology; D010741:Phospholipases A / Q000378:metabolism / Q000494:pharmacology; D054467:Phospholipases A2; D010791:Phrenic Nerve / Q000187:drug effects
chemical_list: D000906:Antibodies; D004546:Elapid Venoms; D008081:Liposomes; D009498:Neurotoxins; D018698:Glutamic Acid; D010741:Phospholipases A; D054467:Phospholipases A2